JO3335B1 - مركبات صلصال - Google Patents

مركبات صلصال

Info

Publication number
JO3335B1
JO3335B1 JOP/2011/0140A JOP20110140A JO3335B1 JO 3335 B1 JO3335 B1 JO 3335B1 JO P20110140 A JOP20110140 A JO P20110140A JO 3335 B1 JO3335 B1 JO 3335B1
Authority
JO
Jordan
Prior art keywords
compositions
semi
clay compositions
solid
acute
Prior art date
Application number
JOP/2011/0140A
Other languages
English (en)
Inventor
Didier Kubiak
Nathalie Mondoly
Jeremiah Harnett
Beatrice Hacher
Original Assignee
Ipsen Pharma Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsen Pharma Sas filed Critical Ipsen Pharma Sas
Application granted granted Critical
Publication of JO3335B1 publication Critical patent/JO3335B1/ar

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N17/00—Investigating resistance of materials to the weather, to corrosion, or to light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N11/00—Investigating flow properties of materials, e.g. viscosity, plasticity; Analysing materials by determining flow properties
    • G01N11/10—Investigating flow properties of materials, e.g. viscosity, plasticity; Analysing materials by determining flow properties by moving a body within the material
    • G01N11/14—Investigating flow properties of materials, e.g. viscosity, plasticity; Analysing materials by determining flow properties by moving a body within the material by using rotary bodies, e.g. vane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Ecology (AREA)
  • Environmental & Geological Engineering (AREA)
  • Environmental Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

يتعلق هذا الاختراع بتركيبات صيدلانية سائلة أو شبه صلبة، وعلى الأخص يتعلق بتعليق صيدلاني مائي أو معجون شبه صلب يحتوي على طين المعان الطبيعي. وتكون هذه التركيبات مفيدة بشكل خاص لعلاج مرض الإسهال الحاد والمزمن.
JOP/2011/0140A 2010-04-29 2011-04-25 مركبات صلصال JO3335B1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10290225A EP2386289A1 (en) 2010-04-29 2010-04-29 Clay compositions

Publications (1)

Publication Number Publication Date
JO3335B1 true JO3335B1 (ar) 2019-03-13

Family

ID=43085912

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2011/0140A JO3335B1 (ar) 2010-04-29 2011-04-25 مركبات صلصال

Country Status (22)

Country Link
US (1) US9511023B2 (ar)
EP (3) EP2386289A1 (ar)
JP (2) JP5809244B2 (ar)
KR (1) KR101784032B1 (ar)
CN (2) CN102869342B (ar)
AU (2) AU2011246978B2 (ar)
BR (1) BR112012023532A2 (ar)
CA (1) CA2795613C (ar)
EA (2) EA021301B1 (ar)
ES (1) ES2657707T3 (ar)
HK (1) HK1223565A1 (ar)
HU (1) HUE035714T2 (ar)
JO (1) JO3335B1 (ar)
MA (1) MA34100B1 (ar)
MX (1) MX2012012412A (ar)
PL (1) PL2563332T3 (ar)
PT (1) PT2563332T (ar)
TN (1) TN2012000451A1 (ar)
TR (1) TR201802106T4 (ar)
TW (2) TWI538679B (ar)
UA (1) UA108377C2 (ar)
WO (1) WO2011135461A2 (ar)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8778398B2 (en) 2008-11-04 2014-07-15 Jazz Pharmaceuticals, Inc. Immediate release formulations and dosage forms of gamma-hydroxybutyrate
CA2794171C (en) 2010-03-24 2018-07-03 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
EP2386289A1 (en) * 2010-04-29 2011-11-16 Ipsen Pharma S.A.S. Clay compositions
EP3023093B1 (en) * 2014-11-20 2017-07-26 S.I.I.T. S.r.l.-Servizio Internazionale Imballaggi Termosaldanti Medicinal preparation based on diosmectite
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
US10506058B2 (en) * 2016-03-18 2019-12-10 Qualcomm Incorporated Signaling of application content packaging and delivery
ITUA20162277A1 (it) * 2016-04-04 2017-10-04 Chemists Res Srl Composizione comprendente diosmectite
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12186296B1 (en) 2016-07-22 2025-01-07 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US12478604B1 (en) 2016-07-22 2025-11-25 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
CN106344618A (zh) * 2016-10-09 2017-01-25 东南大学 用于预防与治疗免疫失调症、肠炎和孤独症的土壤制剂
US20180263936A1 (en) 2017-03-17 2018-09-20 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
CN106924283A (zh) * 2017-03-29 2017-07-07 成都维恒医药科技有限公司 一种含蒙脱石、药用活性炭的止泻药物组合物及制备方法和用途
CN108721325B (zh) * 2017-04-13 2020-03-06 辽宁大熊制药有限公司 蒙脱石混悬液及其制备方法
CA3115122A1 (en) 2018-11-19 2020-05-28 Jazz Pharmaceuticals Ireland Limited Alcohol-resistant drug formulations
EP3930702A1 (en) 2019-03-01 2022-01-05 Flamel Ireland Limited Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
KR102035479B1 (ko) 2019-04-12 2019-10-23 한국지질자원연구원 점토광물 복합체를 포함하는 방출성이 제어된 경구투여용 조성물
TW202139986A (zh) 2020-02-21 2021-11-01 愛爾蘭商爵士製藥愛爾蘭有限責任公司 治療原發性嗜睡症之方法
WO2022076824A1 (en) 2020-10-08 2022-04-14 Jazz Pharmaceuticals Ireland Limited Sodium oxybate to treat idiopathic hypersomnia
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
JP2026513019A (ja) 2023-02-03 2026-04-22 トリス・フアルマ・インコーポレーテツド １晩１回の低ナトリウムオキシベート組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE564287A (ar) 1957-01-28
US3141875A (en) 1961-03-15 1964-07-21 Fmc Corp Crystallite aggregates disintegrated in acid medium
JPH064530B2 (ja) * 1985-02-23 1994-01-19 日本化薬株式会社 親水性基剤
GB8512345D0 (en) * 1985-05-15 1985-06-19 Scras Anti-diarrhea compositions
US5770217A (en) * 1997-07-02 1998-06-23 Atlatl, Inc. Dietary supplement for hematological, immune and appetite enhancement
US20010016577A1 (en) * 1998-08-24 2001-08-23 Douglas Joseph Dobrozsi Oral mucoadhesive compositions containing gastrointestinal actives
CN1326745A (zh) * 2000-06-01 2001-12-19 翟永功 蒙脱石为胃肠道药物的成份
US7101888B2 (en) * 2002-08-28 2006-09-05 Pharmacia & Upjohn Company Oral liquid tolterodine composition
RU2004129624A (ru) * 2003-10-03 2006-03-10 Стрикс Лимитед (Gb) Сосуд для хранения воды
EP1677755A4 (en) * 2003-10-28 2011-12-28 Taro Pharmaceuticals Usa Inc FORMULATIONS BASED ON RINGS AT THE D BORDEMENT
US20070031512A1 (en) * 2005-08-03 2007-02-08 Amcol International Corporation Virus-interacting layered phyllosilicates and methods of inactivating viruses
CA2656433A1 (en) * 2006-07-17 2008-01-24 Nestec S.A. Healthy and nutritious low calorie, low fat foodstuffs
FR2912059B1 (fr) * 2007-02-06 2013-04-05 Scras Utilisation d'argiles pour le traitement de la maladie coeliaque
CN101112387B (zh) * 2007-08-06 2011-04-13 南京白敬宇制药有限责任公司 一种治疗非感染性腹泻的蒙脱石混悬液及其制备方法
CN101129326A (zh) * 2007-08-15 2008-02-27 济南康众医药科技开发有限公司 一种蒙脱石混悬剂制备方法
EP2386289A1 (en) * 2010-04-29 2011-11-16 Ipsen Pharma S.A.S. Clay compositions

Also Published As

Publication number Publication date
AU2011246978A1 (en) 2012-11-22
EP3326610A1 (en) 2018-05-30
EA201291125A1 (ru) 2013-04-30
EP2563332B1 (en) 2017-11-15
WO2011135461A3 (en) 2012-03-01
PT2563332T (pt) 2018-02-08
UA108377C2 (xx) 2015-04-27
JP2013525418A (ja) 2013-06-20
TN2012000451A1 (en) 2014-01-30
JP6073998B2 (ja) 2017-02-01
HUE035714T2 (en) 2018-05-28
KR20130060218A (ko) 2013-06-07
EA021301B1 (ru) 2015-05-29
AU2011246978B2 (en) 2016-04-28
TWI554274B (zh) 2016-10-21
WO2011135461A2 (en) 2011-11-03
CN105520954A (zh) 2016-04-27
AU2016208328B2 (en) 2017-12-21
ES2657707T3 (es) 2018-03-06
KR101784032B1 (ko) 2017-10-10
PL2563332T3 (pl) 2018-04-30
AU2016208328A1 (en) 2016-08-11
EP2563332A2 (en) 2013-03-06
TW201141492A (en) 2011-12-01
BR112012023532A2 (pt) 2016-07-26
JP5809244B2 (ja) 2015-11-10
EA201400903A1 (ru) 2014-11-28
TW201601733A (zh) 2016-01-16
CA2795613C (en) 2017-11-21
HK1223565A1 (zh) 2017-08-04
MA34100B1 (ar) 2013-03-05
TWI538679B (zh) 2016-06-21
US20130059016A1 (en) 2013-03-07
MX2012012412A (es) 2012-12-17
EA026052B1 (ru) 2017-02-28
CA2795613A1 (en) 2011-11-03
US9511023B2 (en) 2016-12-06
CN102869342B (zh) 2016-01-06
EP2386289A1 (en) 2011-11-16
JP2016020373A (ja) 2016-02-04
TR201802106T4 (tr) 2018-03-21
CN102869342A (zh) 2013-01-09

Similar Documents

Publication Publication Date Title
JO3335B1 (ar) مركبات صلصال
JOP20180102A1 (ar) مركب صيدلاني
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
MY203474A (en) Substituted tricyclic compounds as fgfr inhibitors
PH12013500145B1 (en) Agonists of gpr40
EA201200551A1 (ru) Фармацевтическая композиция, фармацевтическая дозированная форма, способы их получения и применения для лечения
EA201491412A1 (ru) Соединения для лечения спинальной мышечной атрофии
EA201491766A1 (ru) Соединения для лечения спинальной мышечной атрофии
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
MX2015001719A (es) Composiciones cosmeticas.
EA201590617A1 (ru) Композиции алкилированного циклодекстрина и способы их получения и применения
PH12014501032A1 (en) 2-thiopyrimidinones
WO2010147830A3 (en) Aminothiazole modulators of beta-3-adrenoreceptor
GEP201606514B (en) Apoptosis inhibitors and usage thereof
EA201200545A1 (ru) Производные пиразола, которые модулируют стеароил-соа десатуразу
MX366829B (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
EA201291354A1 (ru) Новое применение диатомитовой земли в фармацевтической промышленности
UA103996C2 (en) Ivabradine hydrobromide
MX2015009348A (es) Composiciones hemostaticas.
UA116207C2 (uk) Виділена тверда форма моногідрохлориду анамореліну та фармацевтична композиція, що її містить
UA110131C2 (ru) ПРОИЗВОДНЫЕ ТИЕНО[2,3-d]ПИРИМИДИНА И ИХ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ АРИТМИИ
WO2012154879A3 (en) Autophagy inhibitors
MX350569B (es) Composicion farmaceutica estable para el tratamiento de osteoporosis.
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
TR201009166A2 (tr) Sefdinir içeren farmasötik bileşim için üretim yöntemi